Skip to main content
. 2021 Jun 23;19:189. doi: 10.1186/s12951-021-00935-z

Fig. 4.

Fig. 4

In vivo biodistribution of FeSiNTs/FAM-siSPAG5 monitored using in vivo imaging. A In vivo imaging of T24 xenograft-bearing mice after intratumoural injection of FeSiNTs/FAM-siSPAG5, free FAM-siSPAG5, FeSiNTs, or PBS (n = 5 mice in each group). BE In vivo imaging of T24 xenograft-bearing mice 0.5 h (B), 4 h (C), 8 h (D), and 16 h (E) after tail vein injection of FeSiNTs/FAM-siSPAG5, free FAM-siSPAG5, FeSiNTs, or PBS (n = 5 mice in each group)